Trust CO Of Vermont Novartis Ag Transaction History

Trust CO Of Vermont

  • $2.01 Billion
  • Q4 2024

A detailed history of Trust CO Of Vermont transactions in Novartis Ag stock. As of the latest transaction made, Trust CO Of Vermont holds 47,968 shares of NVS stock, worth $5.06 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
47,968
Previous 48,365 0.82%
Holding current value
$5.06 Million
Previous $5.56 Million 16.09%
% of portfolio
0.23%
Previous 0.28%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025
SELL
$96.78 - $117.18 $38,421 - $46,520
-397 Reduced 0.82%
47,968 $4.67 Million
Q3 2024

Oct 16, 2024
SELL
$106.13 - $120.89 $33,218 - $37,838
-313 Reduced 0.64%
48,365 $5.56 Million
Q2 2024

Jul 09, 2024
SELL
$92.57 - $107.37 $54,523 - $63,240
-589 Reduced 1.2%
48,678 $5.18 Million
Q1 2024

May 03, 2024
BUY
$95.27 - $108.47 $484,162 - $551,244
5,082 Added 11.5%
49,267 $4.77 Million
Q4 2023

Mar 08, 2024
SELL
$92.27 - $101.54 $807,270 - $888,373
-8,749 Reduced 16.53%
44,185 $4.46 Million
Q3 2023

Nov 27, 2023
SELL
$94.73 - $105.13 $584,673 - $648,862
-6,172 Reduced 10.44%
52,934 $5.39 Million
Q2 2023

Jul 17, 2023
SELL
$92.52 - $104.91 $247,861 - $281,053
-2,679 Reduced 4.34%
59,106 $5.96 Million
Q1 2023

Apr 07, 2023
SELL
$80.03 - $92.81 $48,658 - $56,428
-608 Reduced 0.97%
61,785 $5.68 Million
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $264,953 - $324,467
-3,507 Reduced 5.32%
62,393 $5.66 Million
Q3 2022

Oct 24, 2022
SELL
$74.61 - $87.26 $97,515 - $114,048
-1,307 Reduced 1.94%
65,900 $5.01 Million
Q2 2022

Jul 20, 2022
SELL
$80.52 - $93.75 $122,470 - $142,593
-1,521 Reduced 2.21%
67,207 $5.68 Million
Q1 2022

Apr 05, 2022
SELL
$80.11 - $90.62 $67,452 - $76,302
-842 Reduced 1.21%
68,728 $6.03 Million
Q4 2021

Jan 21, 2022
SELL
$79.7 - $88.13 $238,940 - $264,213
-2,998 Reduced 4.13%
69,570 $6.09 Million
Q3 2021

Oct 22, 2021
SELL
$81.78 - $95.14 $122,015 - $141,948
-1,492 Reduced 2.01%
72,568 $5.93 Million
Q2 2021

Jul 15, 2021
SELL
$85.24 - $94.15 $32,476 - $35,871
-381 Reduced 0.51%
74,060 $6.76 Million
Q1 2021

Apr 16, 2021
SELL
$83.5 - $98.47 $653,471 - $770,626
-7,826 Reduced 9.51%
74,441 $6.36 Million
Q4 2020

Feb 03, 2021
SELL
$78.07 - $94.43 $154,890 - $187,349
-1,984 Reduced 2.35%
82,267 $7.77 Million
Q3 2020

Nov 06, 2020
SELL
$82.14 - $91.0 $215,124 - $238,329
-2,619 Reduced 3.01%
84,251 $7.33 Million
Q2 2020

Jul 17, 2020
SELL
$80.93 - $91.1 $1.83 Million - $2.06 Million
-22,611 Reduced 20.65%
86,870 $7.59 Million
Q1 2020

Apr 24, 2020
BUY
$70.67 - $99.01 $26,995 - $37,821
382 Added 0.35%
109,481 $9.03 Million
Q4 2019

Feb 06, 2020
SELL
$84.35 - $95.37 $88,567 - $100,138
-1,050 Reduced 0.95%
109,099 $10.3 Million
Q3 2019

Oct 24, 2019
SELL
$85.54 - $94.26 $157,906 - $174,003
-1,846 Reduced 1.65%
110,149 $9.57 Million
Q2 2019

Jul 26, 2019
SELL
$75.4 - $92.8 $60,395 - $74,332
-801 Reduced 0.71%
111,995 $10.2 Million
Q1 2019

May 01, 2019
SELL
$75.32 - $86.15 $73,437 - $83,996
-975 Reduced 0.86%
112,796 $10.8 Million
Q4 2018

Jan 30, 2019
SELL
$73.66 - $82.02 $35,798 - $39,861
-486 Reduced 0.43%
113,771 $9.76 Million
Q3 2018

Oct 26, 2018
BUY
$66.94 - $77.43 $16,199 - $18,738
242 Added 0.21%
114,257 $9.85 Million
Q2 2018

Jul 11, 2018
BUY
$64.91 - $73.36 $69,129 - $78,128
1,065 Added 0.94%
114,015 $8.61 Million
Q1 2018

May 18, 2018
BUY
$70.39 - $84.15 $76,936 - $91,975
1,093 Added 0.98%
112,950 $9.13 Million
Q4 2017

Feb 02, 2018
BUY
$72.33 - $77.64 $56,923 - $61,102
787 Added 0.71%
111,857 $9.39 Million
Q3 2017

Oct 24, 2017
BUY
$74.14 - $77.27 $8.23 Million - $8.58 Million
111,070
111,070 $9.54 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email